UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

The oncologist (Dayton, Ohio), 2020-02, Vol.25 (2), p.e328-e334

2020

Volltextzugriff (PDF)

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

Clinical cancer research, 2020-01, Vol.26 (2), p.328-331

2020

Volltextzugriff (PDF)

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis

Leukemia, 2020-11, Vol.34 (11), p.3082-3084

2020

Volltextzugriff (PDF)

Damage associated molecular pattern molecules

Clinical immunology (Orlando, Fla.), 2007-07, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

An Adenoviral Vector Cancer Vaccine That Delivers a Tumor-Associated Antigen/CD40-Ligand Fusion Protein to Dendritic Cells

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.15101-15106

2003

Volltextzugriff (PDF)

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

Journal of Virology, 2004-01, Vol.78 (1), p.116-123

2004

Volltextzugriff (PDF)

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

Investigative ophthalmology & visual science, 2004-07, Vol.45 (7), p.2407-2412

2004

Volltextzugriff (PDF)

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Clinical cancer research, 2019-06, Vol.25 (11), p.3205-3209

2019

Volltextzugriff (PDF)

Abstract 5911: A bicistronic adenoviral vector carrying cytosine deaminase and GM-CSF genes significantly improves antitumor immunity and overall survival in colon cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5911-5911

2018

Volltextzugriff (PDF)

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Blood, 2018-11, Vol.132 (Supplement 1), p.288-288

2018

Volltextzugriff (PDF)

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Blood, 2018-11, Vol.132 (Supplement 1), p.2670-2670

2018

Volltextzugriff (PDF)

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Blood, 2019-11, Vol.134 (Supplement_1), p.3497-3497

2019

Volltextzugriff (PDF)

Intramuscular (IM) or intravenous (IV): Impact of Erwinia asparaginase route of administration on asparaginase activity

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.10031-10031

2015

Volltextzugriff (PDF)

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

The oncologist (Dayton, Ohio), 2019-10

2019

Volltextzugriff (PDF)

High and Low Levels of Cottontail Rabbit Papillomavirus E2 Protein Generate Opposite Effects on Gene Expression

The Journal of biological chemistry, 2001-01, Vol.276 (2), p.867-874

2001

Volltextzugriff (PDF)

FOCiS on Damage Associated Molecular Pattern Molecules

Clinical immunology (Orlando, Fla.), 2007-04, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

Chemotherapy Targeted to Cancer Tissue Potentiates Antigen-specific Immune Response Induced by Vaccine for In Vivo Antigen Loading and Activation of Dendritic Cells

Molecular therapy, 2008-10, Vol.16 (10), p.1753-1760

2008

Volltextzugriff (PDF)

Gene therapy of cancer

Breast cancer (Tokyo, Japan), 1997-12, Vol.4 (4), p.209-209

1997

Volltextzugriff (PDF)

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44+CD24−/Low Cancer Stem Cells in Epithelial Neoplasms

Blood, 2008-11, Vol.112 (11), p.2908-2908

2008

Volltextzugriff (PDF)

TAA/ecdCD40L VPP Vaccination Induces Robust Adaptive Immune Response Even in Individuals with Post Transplantation Lymphopenia

Blood, 2008-11, Vol.112 (11), p.363-363

2008

Volltextzugriff (PDF)

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged : Imapct of aging on cancer immunity and immunotherapy

Cancer immunology and immunotherapy, 2009, Vol.58 (12), p.1949-1957

2009

Volltextzugriff (PDF)

Vaccine for Cancer and Infectious Diseases (B194)

The Journal of immunology (1950), 2007-04, Vol.178 (1_Supplement), p.LB40-LB41

2007

Volltextzugriff (PDF)

Vector Prime-Protein Boost Vaccine Induces Immune Response Against “Self-Antigens” Associated with Epithelial Neoplasms and Tumor Vascular Endothelial Cells

Blood, 2005-11, Vol.106 (11), p.5533-5533

2005

Volltextzugriff (PDF)

Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation

Blood, 1996-12, Vol.88 (11), p.4383-4389

1996

Volltextzugriff (PDF)

Loss of Imprinting in Disease Progression in Chronic Myelogenous Leukemia

Blood, 1998-05, Vol.91 (9), p.3144-3147

1998

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis

Damage associated molecular pattern molecules

An Adenoviral Vector Cancer Vaccine That Delivers a Tumor-Associated Antigen/CD40-Ligand Fusion Protein to Dendritic Cells

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Abstract 5911: A bicistronic adenoviral vector carrying cytosine deaminase and GM-CSF genes significantly improves antitumor immunity and overall survival in colon cancer

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Response Rate, Event-Free Survival (EFS), and Overall Survival (OS) in Newly-Diagnosed Acute Myeloid Leukemia (AML): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses

Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis

Intramuscular (IM) or intravenous (IV): Impact of Erwinia asparaginase route of administration on asparaginase activity

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

High and Low Levels of Cottontail Rabbit Papillomavirus E2 Protein Generate Opposite Effects on Gene Expression

FOCiS on Damage Associated Molecular Pattern Molecules

Chemotherapy Targeted to Cancer Tissue Potentiates Antigen-specific Immune Response Induced by Vaccine for In Vivo Antigen Loading and Activation of Dendritic Cells

Gene therapy of cancer

Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44+CD24−/Low Cancer Stem Cells in Epithelial Neoplasms

TAA/ecdCD40L VPP Vaccination Induces Robust Adaptive Immune Response Even in Individuals with Post Transplantation Lymphopenia

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged : Imapct of aging on cancer immunity and immunotherapy

Vaccine for Cancer and Infectious Diseases (B194)

Vector Prime-Protein Boost Vaccine Induces Immune Response Against “Self-Antigens” Associated with Epithelial Neoplasms and Tumor Vascular Endothelial Cells

Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation

Loss of Imprinting in Disease Progression in Chronic Myelogenous Leukemia

Aktive Filter

Suchergebnisse filtern